Andere Sprachen Alembic Limited

Aktien

A3C32D

INE426A01027

ALEMBICLTD

Markt geschlossen - Bombay S.E. Andere Börsenplätze 12:00:51 31.05.2024			% 5 Tage	% 1. Jan.
98.68 ^INR	-0.12%		-4.39%	+8.91%

30.05.	Alembic Pharmaceuticals erhält endgültige Genehmigung der US FDA für Sacubitril und Valsartan Tabletten	MT
13.05.	Alembic Limited empfiehlt Dividende für das Jahr bis zum 31. März 2024	CI

Andere Sprachen

Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!

100% kostenlose Registrierung

Alembic Pharmaceuticals Gets US FDA Final Nod for Sacubitril and Valsartan Tablets	30.05.
Alembic Limited Recommends Dividend for the Year Ended 31 March, 2024	13.05.
Alembic Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	13.05.
Alembic Pharmaceuticals' Consolidated Net Profit Jumps in Fiscal Q4	09.05.
India's Alembic Pharma posts higher Q4 profit on strong N.America sales	09.05.
Alembic Pharmaceuticals Gets US FDA Tentative Nod for Generic Breast Cancer Treatment	02.04.
Alembic Limited Announces Cessation of C. P. Buch as an Independent Director	01.04.
Crisil Keeps AA+ Rating on Alembic Pharmaceuticals' Bank Loans with Stable Outlook	08.03.
ICRA Affirms AA- Rating on Alembic's Bank Financing; Outlook Stable	29.02.
Indian shares seen muted tracking broader Asian equities	26.02.
Alembic Pharmaceuticals Fully Resumes Operations at Manufacturing Unit in South Sikkim, India	23.02.
Alembic Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	14.02.
Alembic Pharmaceuticals' Consolidated Net Profit Jumps in Fiscal Q3; EPS Tops Estimates	06.02.
Alembic Pharmaceuticals' Consolidated Profit Climbs in Fiscal Q3, EPS Beats Estimates	06.02.
India's Alembic Pharma beats Q3 profit view on strong domestic, US sales	05.02.
Alembic Pharmaceuticals Expects Operations at Sikkim, India Units to Be Restores in Two Months	05.01.
Alembic Pharmaceuticals Extends Corporate Guarantee to US-Based Arm to Secure Credit	03.01.
Alembic Pharmaceuticals Logs Slightly Higher Consolidated Profit in Fiscal Q2; EPS Misses Estimates	08.11.
India's Alembic Pharma Q2 profit roughly in-line with estimates	07.11.
Alembic Limited Appoints Dr. Girish Hirode as an Independent Director of the Company	10.08.23

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Alembic Limited

Aktien

A3C32D

INE426A01027

ALEMBICLTD

Andere Sprachen

Filter